These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 21992534)

  • 1. Clinical outcomes and changes in aqueous vascular endothelial growth factor levels after intravitreal bevacizumab for iris neovascularization and neovascular glaucoma: a retrospective two-dose comparative study.
    Sasamoto Y; Oshima Y; Miki A; Wakabayashi T; Song D; Matsushita K; Hamasaki T; Nishida K
    J Ocul Pharmacol Ther; 2012 Feb; 28(1):41-8. PubMed ID: 21992534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
    Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y
    Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of erythropoietin and vascular endothelial growth factor in surgery-required advanced neovascular glaucoma eyes before and after intravitreal injection of bevacizumab.
    Zhou M; Chen S; Wang W; Huang W; Cheng B; Ding X; Zhang X
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):3874-9. PubMed ID: 23674760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal bevacizumab for neovascular glaucoma: a randomized controlled trial.
    Yazdani S; Hendi K; Pakravan M; Mahdavi M; Yaseri M
    J Glaucoma; 2009; 18(8):632-7. PubMed ID: 19826393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal bevacizumab and aqueous shunting surgery for neovascular glaucoma: safety and efficacy.
    Eid TM; Radwan A; el-Manawy W; el-Hawary I
    Can J Ophthalmol; 2009 Aug; 44(4):451-6. PubMed ID: 19606170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of intravitreal bevacizumab in eyes with neovascular glaucoma undergoing Ahmed glaucoma valve implantation: 2-year follow-up.
    Arcieri ES; Paula JS; Jorge R; Barella KA; Arcieri RS; Secches DJ; Costa VP
    Acta Ophthalmol; 2015 Feb; 93(1):e1-6. PubMed ID: 24989855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal bevacizumab in refractory neovascular glaucoma: a prospective, observational case series.
    Kotecha A; Spratt A; Ogunbowale L; dell'Omo R; Kulkarni A; Bunce C; Franks WA
    Arch Ophthalmol; 2011 Feb; 129(2):145-50. PubMed ID: 21320957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracameral bevacizumab (Avastin) for neovascular glaucoma: a pilot study in 6 patients.
    Duch S; Buchacra O; Milla E; Andreu D; Tellez J
    J Glaucoma; 2009 Feb; 18(2):140-3. PubMed ID: 19225351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intravitreal bevacizumab on iris vessels in neovascular glaucoma patients.
    Sugimoto Y; Mochizuki H; Okumichi H; Takumida M; Takamatsu M; Kawamata S; Kiuchi Y
    Graefes Arch Clin Exp Ophthalmol; 2010 Nov; 248(11):1601-9. PubMed ID: 20524132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical bevacizumab for neovascular glaucoma: a pilot study.
    Waisbourd M; Shemesh G; Kurtz S; Rachmiel R; Moisseiev E; Zayit-Soudri S; Loewenstein A; Barequet I
    Pharmacology; 2014; 93(3-4):108-12. PubMed ID: 24556733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentration of vascular endothelial growth factor after intracameral bevacizumab injection in eyes with neovascular glaucoma.
    Lim TH; Bae SH; Cho YJ; Lee JH; Kim HK; Sohn YH
    Korean J Ophthalmol; 2009 Sep; 23(3):188-92. PubMed ID: 19794946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab.
    Moraczewski AL; Lee RK; Palmberg PF; Rosenfeld PJ; Feuer WJ
    Br J Ophthalmol; 2009 May; 93(5):589-93. PubMed ID: 19074917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term effect of intravitreal ranibizumab on intraocular concentrations of vascular endothelial growth factor-A and pigment epithelium-derived factor in neovascular glaucoma.
    Wang JW; Zhou MW; Zhang X; Huang WB; Gao XB; Wang W; Chen S; Zhang XY; Ding XY; Jonas JB
    Clin Exp Ophthalmol; 2015 Jul; 43(5):415-21. PubMed ID: 25488632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical results of Ahmed valve implantation with intraoperative bevacizumab injection in patients with neovascular glaucoma.
    Ma KT; Yang JY; Kim JH; Kim NR; Hong S; Lee ES; Seong GJ; Kim CY
    J Glaucoma; 2012; 21(5):331-6. PubMed ID: 21673594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined intravitreal bevacizumab and trabeculectomy with mitomycin C versus trabeculectomy with mitomycin C alone for neovascular glaucoma.
    Takihara Y; Inatani M; Kawaji T; Fukushima M; Iwao K; Iwao M; Tanihara H
    J Glaucoma; 2011 Mar; 20(3):196-201. PubMed ID: 20440215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-VEGF intravitreal bevacizumab for radiation-associated neovascular glaucoma.
    Nagendran ST; Finger PT
    Ophthalmic Surg Lasers Imaging Retina; 2015 Feb; 46(2):201-7. PubMed ID: 25707045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjunctive with versus without intravitreal bevacizumab injection before Ahmed glaucoma valve implantation in the treatment of neovascular glaucoma.
    Zhou MW; Wang W; Huang WB; Chen SD; Li XY; Gao XB; Zhang XL
    Chin Med J (Engl); 2013; 126(8):1412-7. PubMed ID: 23595369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of intravitreal bevacizumab injection before Ahmed glaucoma valve implantation in neovascular glaucoma.
    Sevim MS; Buttanri IB; Kugu S; Serin D; Sevim S
    Ophthalmologica; 2013; 229(2):94-100. PubMed ID: 23364308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous increase in multiple proinflammatory cytokines in the aqueous humor in neovascular glaucoma with and without intravitreal bevacizumab injection.
    Ohira S; Inoue T; Shobayashi K; Iwao K; Fukushima M; Tanihara H
    Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):3541-8. PubMed ID: 26030108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aqueous humor levels of vascular endothelial growth factor before and after intravitreal bevacizumab in type 3 versus type 1 and 2 neovascularization. A prospective, case-control study.
    dell'Omo R; Cassetta M; dell'Omo E; di Salvatore A; Hughes JM; Aceto F; Porcellini A; Costagliola C
    Am J Ophthalmol; 2012 Jan; 153(1):155-61.e2. PubMed ID: 21861975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.